Acosta, Brian – Trademark Portfolio

Entity Type: 01

Acosta, Brian holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RAW WARRIOR and MATRIX BUSINESS CAPITAL. The owner is based in Long Beach, CA.

401 East Ocean Blvd., Suite 401

401 East Ocean Blvd.

Long Beach, CA 90802

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Acosta, Brian's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (3 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Acosta, Brian have?

Acosta, Brian has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Acosta, Brian file in?

Acosta, Brian files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Acosta, Brian's most well-known trademarks?

Acosta, Brian's registered trademark portfolio includes well-known marks such as RAW WARRIOR and MATRIX BUSINESS CAPITAL. These are among 2 currently registered trademarks in the portfolio.

What is Acosta, Brian's trademark registration success rate?

Acosta, Brian has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.